| pubmed-article:20680543 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20680543 | lifeskim:mentions | umls-concept:C1196049 | lld:lifeskim |
| pubmed-article:20680543 | lifeskim:mentions | umls-concept:C0014257 | lld:lifeskim |
| pubmed-article:20680543 | lifeskim:mentions | umls-concept:C0086045 | lld:lifeskim |
| pubmed-article:20680543 | lifeskim:mentions | umls-concept:C0178719 | lld:lifeskim |
| pubmed-article:20680543 | lifeskim:mentions | umls-concept:C0442805 | lld:lifeskim |
| pubmed-article:20680543 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
| pubmed-article:20680543 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:20680543 | lifeskim:mentions | umls-concept:C0596235 | lld:lifeskim |
| pubmed-article:20680543 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:20680543 | lifeskim:mentions | umls-concept:C1514485 | lld:lifeskim |
| pubmed-article:20680543 | lifeskim:mentions | umls-concept:C0056539 | lld:lifeskim |
| pubmed-article:20680543 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:20680543 | pubmed:dateCreated | 2010-11-2 | lld:pubmed |
| pubmed-article:20680543 | pubmed:abstractText | Proteinase inhibitors, isolated from different types of Bauhinia, have an effect on apoptosis, angiogenesis and inflammation. The Bauhinia bauhinioides cruzipain inhibitor (BbCI) is a Kunitz-type inhibitor and inactivates the cysteine proteinases cruzipain and cruzain from Trypanosoma cruzi. Cruzipain and tissue kallikrein have similar biochemical properties, e.g. the proteolytic cleavage of the kininogen precursor of lys-bradykinin. Tissue kallikrein stimulation in endothelial cells causes migration and capillary tube formation. The aim of this study was to examine whether the antiproliferative effect of BbCI is dependent on changes of the intracellular calcium concentration and membrane hyperpolarization. Endothelial cells were isolated from human umbilical cord veins (HUVEC). For proliferation experiments, HUVEC were incubated with BbCI (10-100 ?mol/L) for 48 h. The proliferation was detected by cell counting with a Neubauer chamber. The effect of BbCI (10-100 ?M) on the membrane potential was measured with the fluorescence dye DiBAC4(3) and the effect on [Ca+2]i with the fluorescence probe Fluo-3 AM. The change of the fluorescence intensity was determined with a GENios plate reader (Tecan). The experiments showed that BbCI (10-100 ?mol/L) reduces the endothelial cell proliferation significantly in a concentration-dependent manner with a maximum effect at 100 ?mol/L (35.1±1.8% as compared to control (p?0.05; n=45)). As compared to the control, the addition of BbCI (100 ?mol/L) caused a significant increase of systolic Ca2+ of 28.4±5.0% after 30 min incubation. HUVEC treatment with BbCI (100 ?mol/L) showed a weak but significant decrease of the membrane potential of 9.5±0.9% as compared to control (p?0.05; n=80). BbCI influenced significantly the endothelial proliferation, the intracellular Ca2+ concentration and the membrane potential. | lld:pubmed |
| pubmed-article:20680543 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20680543 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20680543 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20680543 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20680543 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20680543 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20680543 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20680543 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20680543 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20680543 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20680543 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:20680543 | pubmed:issn | 1138-7548 | lld:pubmed |
| pubmed-article:20680543 | pubmed:author | pubmed-author:ErdoganAliA | lld:pubmed |
| pubmed-article:20680543 | pubmed:author | pubmed-author:NeuhofChristi... | lld:pubmed |
| pubmed-article:20680543 | pubmed:author | pubmed-author:AbdallahYaser... | lld:pubmed |
| pubmed-article:20680543 | pubmed:author | pubmed-author:BilginMehmetM | lld:pubmed |
| pubmed-article:20680543 | pubmed:author | pubmed-author:AndradeSheila... | lld:pubmed |
| pubmed-article:20680543 | pubmed:author | pubmed-author:BenscheidUtzU | lld:pubmed |
| pubmed-article:20680543 | pubmed:author | pubmed-author:MostAstridA | lld:pubmed |
| pubmed-article:20680543 | pubmed:author | pubmed-author:ParahulevaMar... | lld:pubmed |
| pubmed-article:20680543 | pubmed:author | pubmed-author:DoerrOliverO | lld:pubmed |
| pubmed-article:20680543 | pubmed:author | pubmed-author:GuenduezDursu... | lld:pubmed |
| pubmed-article:20680543 | pubmed:author | pubmed-author:OlivaMaria... | lld:pubmed |
| pubmed-article:20680543 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20680543 | pubmed:volume | 66 | lld:pubmed |
| pubmed-article:20680543 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20680543 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20680543 | pubmed:pagination | 283-90 | lld:pubmed |
| pubmed-article:20680543 | pubmed:meshHeading | pubmed-meshheading:20680543... | lld:pubmed |
| pubmed-article:20680543 | pubmed:meshHeading | pubmed-meshheading:20680543... | lld:pubmed |
| pubmed-article:20680543 | pubmed:meshHeading | pubmed-meshheading:20680543... | lld:pubmed |
| pubmed-article:20680543 | pubmed:meshHeading | pubmed-meshheading:20680543... | lld:pubmed |
| pubmed-article:20680543 | pubmed:meshHeading | pubmed-meshheading:20680543... | lld:pubmed |
| pubmed-article:20680543 | pubmed:meshHeading | pubmed-meshheading:20680543... | lld:pubmed |
| pubmed-article:20680543 | pubmed:meshHeading | pubmed-meshheading:20680543... | lld:pubmed |
| pubmed-article:20680543 | pubmed:meshHeading | pubmed-meshheading:20680543... | lld:pubmed |
| pubmed-article:20680543 | pubmed:meshHeading | pubmed-meshheading:20680543... | lld:pubmed |
| pubmed-article:20680543 | pubmed:meshHeading | pubmed-meshheading:20680543... | lld:pubmed |
| pubmed-article:20680543 | pubmed:meshHeading | pubmed-meshheading:20680543... | lld:pubmed |
| pubmed-article:20680543 | pubmed:meshHeading | pubmed-meshheading:20680543... | lld:pubmed |
| pubmed-article:20680543 | pubmed:meshHeading | pubmed-meshheading:20680543... | lld:pubmed |
| pubmed-article:20680543 | pubmed:meshHeading | pubmed-meshheading:20680543... | lld:pubmed |
| pubmed-article:20680543 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20680543 | pubmed:articleTitle | Bauhinia bauhinioides cruzipain inhibitor reduces endothelial proliferation and induces an increase of the intracellular Ca2+ concentration. | lld:pubmed |
| pubmed-article:20680543 | pubmed:affiliation | Department of Cardiology and Angiology, Justus-Liebig-University of Giessen, Klinikstrasse 36, 35392, Giessen, Germany. | lld:pubmed |
| pubmed-article:20680543 | pubmed:publicationType | Journal Article | lld:pubmed |
